Annual Shareholders Equity
$11.46 M
-$3.40 M-22.88%
30 June 2024
Summary:
NanoViricides annual stockholders equity is currently $11.46 million, with the most recent change of -$3.40 million (-22.88%) on 30 June 2024. During the last 3 years, it has fallen by -$18.45 million (-61.67%). NNVC annual shareholders equity is now -63.93% below its all-time high of $31.79 million, reached on 30 June 2015.NNVC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$10.11 M
-$1.36 M-11.83%
01 September 2024
Summary:
NanoViricides quarterly stockholders equity is currently $10.11 million, with the most recent change of -$1.36 million (-11.83%) on 01 September 2024. Over the past year, it has dropped by -$2.86 million (-22.06%). NNVC quarterly shareholders equity is now -72.55% below its all-time high of $36.83 million, reached on 30 September 2014.NNVC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NNVC Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.9% | -22.1% |
| 3 y3 years | -61.7% | -64.3% |
| 5 y5 years | +8.2% | +10.7% |
NNVC Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -61.7% | at low | -64.3% | at low |
| 5 y | 5 years | -61.7% | +8.2% | -68.3% | +30.9% |
| alltime | all time | -63.9% | >+9999.0% | -72.5% | +4327.4% |
NanoViricides Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.11 M(-11.8%) |
| June 2024 | $11.46 M(-22.9%) | $11.46 M(+7.6%) |
| Mar 2024 | - | $10.65 M(-14.5%) |
| Dec 2023 | - | $12.45 M(-4.0%) |
| Sept 2023 | - | $12.97 M(-12.8%) |
| June 2023 | $14.87 M(-35.6%) | $14.87 M(-18.4%) |
| Mar 2023 | - | $18.23 M(-8.3%) |
| Dec 2022 | - | $19.87 M(-7.9%) |
| Sept 2022 | - | $21.56 M(-6.6%) |
| June 2022 | $23.08 M(-22.8%) | $23.08 M(-6.8%) |
| Mar 2022 | - | $24.76 M(-6.5%) |
| Dec 2021 | - | $26.47 M(-6.5%) |
| Sept 2021 | - | $28.31 M(-5.4%) |
| June 2021 | $29.91 M(+37.5%) | $29.91 M(-6.2%) |
| Mar 2021 | - | $31.89 M(+14.9%) |
| Dec 2020 | - | $27.75 M(-7.5%) |
| Sept 2020 | - | $29.98 M(+37.8%) |
| June 2020 | $21.76 M(+105.3%) | $21.76 M(+52.0%) |
| Mar 2020 | - | $14.31 M(+85.4%) |
| Dec 2019 | - | $7.72 M(-15.4%) |
| Sept 2019 | - | $9.13 M(-13.9%) |
| June 2019 | $10.60 M(-40.0%) | $10.60 M(-16.6%) |
| Mar 2019 | - | $12.72 M(-8.1%) |
| Dec 2018 | - | $13.84 M(-13.4%) |
| Sept 2018 | - | $15.98 M(-9.5%) |
| June 2018 | $17.66 M(-13.1%) | $17.66 M(-7.7%) |
| Mar 2018 | - | $19.15 M(+20.3%) |
| Dec 2017 | - | $15.92 M(-14.0%) |
| Sept 2017 | - | $18.52 M(-8.9%) |
| June 2017 | $20.32 M(-11.8%) | $20.32 M(-9.3%) |
| Mar 2017 | - | $22.41 M(+17.0%) |
| Dec 2016 | - | $19.15 M(-5.3%) |
| Sept 2016 | - | $20.23 M(-12.2%) |
| June 2016 | $23.05 M(-27.5%) | $23.05 M(-3.9%) |
| Mar 2016 | - | $23.98 M(-15.5%) |
| Dec 2015 | - | $28.38 M(-7.6%) |
| Sept 2015 | - | $30.71 M(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | $31.79 M(+36.0%) | $31.79 M(-0.2%) |
| Mar 2015 | - | $31.86 M(+4.4%) |
| Dec 2014 | - | $30.51 M(-17.2%) |
| Sept 2014 | - | $36.83 M(+57.6%) |
| June 2014 | $23.37 M(+191.8%) | $23.37 M(-27.0%) |
| Mar 2014 | - | $32.03 M(+213.7%) |
| Dec 2013 | - | $10.21 M(-13.1%) |
| Sept 2013 | - | $11.75 M(+46.7%) |
| June 2013 | $8.01 M(-42.2%) | $8.01 M(-20.9%) |
| Mar 2013 | - | $10.12 M(-28.8%) |
| Dec 2012 | - | $14.21 M(+11.1%) |
| Sept 2012 | - | $12.80 M(-7.6%) |
| June 2012 | $13.85 M(+36.2%) | $13.85 M(+2.1%) |
| Mar 2012 | - | $13.57 M(+9.6%) |
| Dec 2011 | - | $12.39 M(+8.8%) |
| Sept 2011 | - | $11.39 M(+11.9%) |
| June 2011 | $10.17 M(+56.0%) | $10.17 M(+12.4%) |
| Mar 2011 | - | $9.05 M(-3.4%) |
| Dec 2010 | - | $9.37 M(+16.7%) |
| Sept 2010 | - | $8.03 M(+23.2%) |
| June 2010 | $6.52 M(+162.3%) | $6.52 M(+83.5%) |
| Mar 2010 | - | $3.55 M(-18.3%) |
| Dec 2009 | - | $4.35 M(-13.3%) |
| Sept 2009 | - | $5.01 M(+101.8%) |
| June 2009 | $2.49 M(+460.2%) | $2.49 M(+31.2%) |
| Mar 2009 | - | $1.90 M(-26.6%) |
| Dec 2008 | - | $2.58 M(-18.0%) |
| Sept 2008 | - | $3.15 M(+610.0%) |
| June 2008 | $443.70 K(-11.3%) | $443.70 K(-67.8%) |
| Mar 2008 | - | $1.38 M(-35.1%) |
| Dec 2007 | - | $2.12 M(-9.3%) |
| Sept 2007 | - | $2.34 M(+367.1%) |
| June 2007 | $500.30 K(-59.6%) | $500.30 K(+119.1%) |
| Mar 2007 | - | $228.30 K(-75.9%) |
| Dec 2006 | - | $945.40 K(-40.8%) |
| Sept 2006 | - | $1.60 M(+29.0%) |
| June 2006 | $1.24 M(-1976.5%) | $1.24 M |
| June 2005 | -$66.00 K | - |
FAQ
- What is NanoViricides annual stockholders equity?
- What is the all time high annual shareholders equity for NanoViricides?
- What is NanoViricides annual shareholders equity year-on-year change?
- What is NanoViricides quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NanoViricides?
- What is NanoViricides quarterly shareholders equity year-on-year change?
What is NanoViricides annual stockholders equity?
The current annual shareholders equity of NNVC is $11.46 M
What is the all time high annual shareholders equity for NanoViricides?
NanoViricides all-time high annual stockholders equity is $31.79 M
What is NanoViricides annual shareholders equity year-on-year change?
Over the past year, NNVC annual stockholders equity has changed by -$3.40 M (-22.88%)
What is NanoViricides quarterly stockholders equity?
The current quarterly shareholders equity of NNVC is $10.11 M
What is the all time high quarterly shareholders equity for NanoViricides?
NanoViricides all-time high quarterly stockholders equity is $36.83 M
What is NanoViricides quarterly shareholders equity year-on-year change?
Over the past year, NNVC quarterly stockholders equity has changed by -$2.86 M (-22.06%)